1. Edible Mushrooms Reduce Atherosclerosis in Ldlr−/− Mice Fed a High-Fat Diet
   Sharon H Kim et al, 2019, The Journal of Nutrition CrossRef
2. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials
   Vaclav Vetvicka et al, 2019, Molecules CrossRef
3. Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future
   Khawaja Muhammad Bashir et al, 2017, International Journal of Molecular Sciences CrossRef
4. β-glucans and cholesterol (Review)
   Petr Sima et al, 2018, International Journal of Molecular Medicine CrossRef
5. Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses
   Yutaro Kobayashi et al, 2018, PLOS ONE CrossRef
6. Hypolipidemic Effects of β-Glucans, Mannans, and Fucoidans: Mechanism of Action and Their Prospects for Clinical Application
   Tatiana A. Korolenko et al, 2020, Molecules CrossRef
7. Dietary Polycan, a β‐glucan originating from Aureobasidium pullulansSM‐2001, attenuates high‐fat‐diet‐induced intestinal barrier damage in obese mice by modulating gut microbiota dysbiosis
   Gwang‐Pyo Ko et al, 2024, Food Science & Nutrition CrossRef
8. β-glucans: a potential source for maintaining gut microbiota and the immune system
   Ravindra Pal Singh et al, 2023, Frontiers in Nutrition CrossRef
9. Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
   Meng-Jie Zhao et al, 2017, Lipids in Health and Disease CrossRef
10. Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nelson Kei et al, 2023, Foods CrossRef
11. A review of the fungal polysaccharides as natural biopolymers: Current applications and future perspective
    Sameh S. Ali et al, 2024, International Journal of Biological Macromolecules CrossRef